Femoxetine hydrochloride

CAS No. 56222-04-9

Femoxetine hydrochloride( —— )

Catalog No. M36272 CAS No. 56222-04-9

Femoxetine hydrochloride is a selective 5-hydroxytryptamine reuptake inhibitor used in the study of migraine, depression and eating disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 212 In Stock
10MG 306 In Stock
25MG 471 In Stock
50MG 643 In Stock
100MG 879 In Stock
200MG 1190 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Femoxetine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Femoxetine hydrochloride is a selective 5-hydroxytryptamine reuptake inhibitor used in the study of migraine, depression and eating disorders.
  • Description
    Femoxetine hydrochloride is a selective 5-hydroxytryptamine reuptake inhibitor used in the study of migraine, depression and eating disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    5-HT Receptor
  • Recptor
    5-HT Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    56222-04-9
  • Formula Weight
    347.88
  • Molecular Formula
    C20H26ClNO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(OC1=CC=C(OC)C=C1)[C@@H]2[C@H](CCN(C)C2)C3=CC=CC=C3.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Felcisetrag

    Felcisetrag (TD-8954) is a potent and selective orally active 5-HT4 agonist with gastrointestinal prokinetic properties.

  • Lesopitron HCl

    Lesopitron HCl is a 5-HT1A receptor agonist with anxiolytic effects that reverses dark avoidance behavior associated with cocaine withdrawal in mice.

  • Spiroxatrine

    Spiroxatrine (R 5188) is a selective and potent 5-HT1α and α2-adrenergic dual antagonist with sedative activity, and inhibitory effects on 5-HT1α, 5-HT1β, 5-HT2, and dopamine receptors.